Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.
D'Amico F, Rubin DT, Kotze PG, Magro F, Siegmund B, Kobayashi T, Olivera PA, Bossuyt P, Pouillon L, Louis E, Domènech E, Ghosh S, Danese S, Peyrin-Biroulet L. D'Amico F, et al. Among authors: siegmund b. United European Gastroenterol J. 2021 May;9(4):451-460. doi: 10.1002/ueg2.12069. Epub 2021 May 7. United European Gastroenterol J. 2021. PMID: 33961734 Free PMC article.
Clinical aspects of inflammatory bowel disease.
Siegmund B, Zeitz M. Siegmund B, et al. Eur J Immunol. 2009 Aug;39(8):2026-30. doi: 10.1002/eji.200939601. Eur J Immunol. 2009. PMID: 19672897 Free article.
[Chronic inflammatory bowel diseases: state of the art].
Maul J, Siegmund B. Maul J, et al. Among authors: siegmund b. Dtsch Med Wochenschr. 2014 Sep;139(36):1771-5. doi: 10.1055/s-0034-1370229. Epub 2014 Aug 26. Dtsch Med Wochenschr. 2014. PMID: 25157865 Review. German.
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M. Kopylov U, et al. Among authors: siegmund b. Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155. Inflamm Bowel Dis. 2018. PMID: 29788318
The role of adipose tissue in inflammatory bowel diseases.
Weidinger C, Hegazy AN, Siegmund B. Weidinger C, et al. Among authors: siegmund b. Curr Opin Gastroenterol. 2018 Jul;34(4):183-186. doi: 10.1097/MOG.0000000000000445. Curr Opin Gastroenterol. 2018. PMID: 29846262 Review.
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.
Jessen B, Rodriguez-Sillke Y, Sonnenberg E, Schumann M, Kruglov A, Freise I, Schmidt F, Maul J, Kühl AA, Glauben R, Lissner D, Siegmund B. Jessen B, et al. Among authors: siegmund b. Clin Gastroenterol Hepatol. 2021 Apr;19(4):721-731.e1. doi: 10.1016/j.cgh.2020.03.066. Epub 2020 Apr 6. Clin Gastroenterol Hepatol. 2021. PMID: 32272247
435 results